Bio Protocol vs Chainflip — how do they compare? Bio Protocol trades at Rp515.63 (market cap Rp1,15T, Rp260,42M 24h volume), while Chainflip trades at Rp5,042 (market cap --, Rp2,14M 24h volume). The key difference: Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Chainflip's keeps growing, and Bio Protocol is more actively traded (Rp260,42M versus Rp2,14M). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Chainflip for 17 Days on average.
| BIO | FLIP | |
|---|---|---|
Market Cap | Rp1,15T | -- |
Volume (24h) | Rp260,42M | Rp2,14M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | -- |
Typical Hold Time | 16 Days | 17 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Chainflip (FLIP) is trading at Rp 5,042 with a bullish technical signal supported by moving averages. Key resistance lies at Rp 5,140, while support is at Rp 4,932. Hold time averages 17 days, indicating moderate holding behavior. No major protocol updates or ecosystem news were reported recently, leaving fundamentals static.
Overall outlook is cautiously optimistic due to bullish technicals, but limited fundamental developments and neutral oscillators suggest volatility. Key opportunities include breakout potential above resistance; major risks involve low liquidity and crypto market volatility. Investors should monitor volume and network activity for confirmation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Chainflip is transforming the decentralized exchange landscape by enabling seamless, low-slippage swaps between major blockchains. Unlike traditional methods, Chainflip removes the need for wrapped tokens or specialized wallets, making cross-chain transactions more accessible and user-friendly. At its core, Chainflip utilizes a Just-In-Time (JIT) Automated Market Maker (AMM) to facilitate efficient and secure trades.
Read more on FLIP →